BEGIN:VCALENDAR
PRODID:NingEventWidget-v1
VERSION:2.0
METHOD:PUBLISH
BEGIN:VTIMEZONE
TZID:America/New_York
X-LIC-LOCATION:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:19700308T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:19701101T020000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
UID:2140535:Event:67083
DTSTAMP:20260524T131751Z
SUMMARY:Webinar on Product Information in the EU
DESCRIPTION:Overview: In order to obtain a marketing authorization, a 
 Summary of Product Characteristics (SmPC) in accordance with Article 1
 1 of Directive 2001/83/EC must be included in the application. In acco
 rdance with Directive 2001/83/EC, when the marketing authorization is 
 issued, the Marketing Authorization Holder shall be informed, by the c
 ompetent authorities of the Member States concerned, of the SmPC as ap
 proved by it. For decisions concerning centralized marketing authoriza
 tions, according to Article 10 of Regulation (EC) No 726/2004, the fin
 al Commission decision with the SmPC is addressed and notified to the 
 Marketing Authorization Holder.\nWhy should you Attend:\nProduct Infor
 mation consist of the Summary of Product Characteristics (SmPC), label
 ling text and package leaflet. The SmPC forms an intrinsic and integra
 l part of the marketing authorization. It sets out the agreed position
  of the medicinal product as distilled during the course of the assess
 ment process. As such the content cannot be changed except with the ap
 proval of the originating competent authority.\nSmPCs are a key part o
 f the marketing authorization of all medicines authorized in the Europ
 ean Union and the basis of information for healthcare professionals on
  how to use a medicine safely and effectively. They are kept updated t
 hroughout the lifecycle of a medicine as new efficacy or safety data e
 merge. The SmPC should be worded in clear and concise language. SmPCs 
 are also the basis for the preparation of package leaflets, so are imp
 ortant documents in enabling information on medicines to reach patient
 s. This webinar provides advice on the principles of presenting inform
 ation in the SmPC.\nThe text on the label and the package leaflet are 
 usually the only items the patient will see from all documents include
 d in a marketing authorization application, so it is very important th
 at the texts are clear and of a high quality. Knowledge of how to writ
 e a package leaflet and which guidance documents are important is also
  vital to pass the so-called “user testing” which is mandatory bef
 ore a medicinal product can be approved in the EU. Deviation from the 
 guidelines should be justified in the Marketing Authorization Applicat
 ions. This webinar provides an overview of the relevant guidance docum
 ents and practical advice of how to write the Product Information.\nAr
 eas Covered in the Session:\nImportant EU product information guidance
  documents for the SmPCDiscussion of each section of the SmPCGuideline
 s on the packaging information and excipientsConsultation with Target 
 Patient Groups\nWho Will Benefit:\nSenior managementProject ManagersMe
 dical writersCRAs and CRCsQA / Compliance personnelInvestigatorsClinic
 al Research ScientistsQA / QC Auditors and StaffConsultants\nSpeaker P
 rofile:\nAdriaan Fruijtier has graduated as a pharmacist at the Univer
 sity of Utrecht, The Netherlands.\nHe is currently Director Regulatory
  Affairs at CATS Consultants. Until March 2004 he has been Head of the
  Oncology Group within Global Regulatory Affairs at Bayer AG, Wupperta
 l, Germany, and Bayer Corporation, West Haven, CT, USA. Between 2001 a
 nd 2003 he was Director of Regulatory Affairs at Micromet AG, a biotec
 h company in Munich, Germany. Prior to joining Micromet he has worked 
 during four years as a Project Manager for Oncology Projects at the Eu
 ropean Medicines Agency in London, United Kingdom.\nContact Detail:\nN
 etZealous - Compliance4All,161 Mission Falls Lane, Suite 216,Fremont, 
 CA 94539, USA.Phone: +1-800-447-9407Email: support@compliance4All.comh
 ttp://www.compliance4all.com/Event Link : http://bit.ly/1WgYDMZ\n\nFo
 r more information visit https://medtechiq.ning.com/events/webinar-on-
 product-information-in-the-eu
DTSTART;TZID=America/New_York:20151217T100000
DTEND;TZID=America/New_York:20151217T110000
CATEGORIES:webinar
LOCATION:Online
WEBSITE:
URL:
CONTACT:8004479407
ORGANIZER;CN="Adam Fleming":https://medtechiq.ning.com/profile/Complia
 nce4all
ATTACH;FMTTYPE="image/jpeg":http://storage.ning.com/topology/rest/1.0/
 file/get/2562012364?profile=original
ATTENDEE;ROLE=REQ-PARTICIPANT;PARTSTAT=ACCEPTED;RSVP=TRUE;CN="Adam Fle
 ming":https://medtechiq.ning.com/profile/Compliance4all
END:VEVENT
END:VCALENDAR
